Editorial: treating hepatorenal syndrome-a window and the views
Aliment Pharmacol Ther
.
2020 Sep;52(5):895-896.
doi: 10.1111/apt.15943.
Authors
Naaventhan Palaniyappan
1
2
,
Guruprasad Padur Aithal
1
2
Affiliations
1
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK.
2
Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
PMID:
32852817
DOI:
10.1111/apt.15943
No abstract available
Publication types
Editorial
Comment
MeSH terms
Hepatorenal Syndrome* / drug therapy
Humans
Lypressin
Terlipressin*
Vasoconstrictor Agents / therapeutic use
Substances
Vasoconstrictor Agents
Lypressin
Terlipressin